A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 48/00 (2006.01) A61P 29/00 (2006.01) A61P 37/00 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2359392
The invention relates to therapies for (auto)immune diseases. Synthesis or presence of apoptotic activity in cells causing or related to (auto)immune diseases, such as synoviocytes in rheumatoid arthritis, will result in the induction of apoptosis. The invention also relates to gene-delivery vehicles, which comprise nucleic acid molecules encoding apoptosis-inducing proteins with apoptin-like activity.
L'invention concerne des thérapies de maladies (auto)immunes. La synthèse ou la présence d'une activité apoptotique dans des cellules provoquant les maladies (auto)immunes, ou associées à celles-ci, telles que les synoviocytes, vont induire l'apoptose. L'invention concerne également des véhicules d'apport de gènes, comprenant des molécules d'acides nucléiques codant pour les protéines induisant l'apoptose et possédant une activité du type apoptine.
Noteborn Mathieu Hubertus Maria
Pietersen Alexandra Maria
Borden Ladner Gervais Llp
Leadd B.v.
LandOfFree
Use of apoptosis inducing agents in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of apoptosis inducing agents in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of apoptosis inducing agents in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1827100